CORPORATE INFORMATION

Our industry has a responsibility to make a positive impact, not only on our consumers' health but also on our planet Earth.

Lipa Pharmaceuticals was established in 1995. It is one of the largest manufacturers of health supplements and complementary medicines in Australia. Lipa Pharmaceuticals Limited is part of the CK Life Sciences Group.

About CK Life Sciences International., (Holdings) Inc.
CK Life Sciences is listed on the Hong Kong Stock Exchange. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in research and development, manufacturing and the sale of products which fall into three core categories - nutraceuticals, pharmaceuticals and agriculture. CK Life Sciences is a member of the CK Hutchinson Group.

Nutraceutical Business
The concept of pre-emptive health management is becoming increasingly important all around the world. Consumers are searching for products to strengthen their health. CK Life Sciences has a portfolio of assets in health products development and marketing that spans North America, Australia and Asia which meets this growing demand. CK Life Sciences' nutraceutical portfolio comprises Santé Naturelle A.G. in Canada, Vitaquest in the United States, and Lipa Pharmaceuticals in Australia.

Pharmaceutical Research
CK Life Sciences' pharmaceutical R&D is focused primarily on cancer vaccines and pain management. CK Life Sciences' mission is to improve quality of life by enhancing human health and the natural environment through the development, application and sale of revolutionary biotechnology solutions. A number of inventions have been granted patents by the United States Patent and Trademark Office.

For additional information, please visit www.ck-lifesciences.com.